Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minoru Yoshida

Showing results (491-500 of 543) with videos related to

Pageof 55
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 7, 2017
Management of infection during chemotherapy for acute leukemia in Japan: a nationwide questionnaire-based survey by the Japan Adult Leukemia Study GroupShun-Ichi Kimura, Hiroyuki Fujita, Hideaki Kato, et al.
International Journal of Hematology|January 8, 2011
Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study GroupMinoru Yoshida, Nobu Akiyama, Hiroyuki Fujita, et al.
Journal of Atherosclerosis and Thrombosis|February 21, 2024
Impaired Cholesterol Efflux Capacity rather than Low HDL-C Reflects Oxidative Stress under Acute Myocardial InfarctionKentaro Oniki, Masatsune Ogura, Erika Matsumoto, et al.
Oncology Reports|September 18, 2004
1-hexylcarbamoyl-5-fluorouracil + cyclophosphamide + tamoxifen versus CMF + tamoxifen in women with lymph node-positive breast cancer after primary surgery: a randomized controlled trialTakeshi Tominaga, Morihiko Kimura, Taro Asaga, et al.
BMC Infectious Diseases|March 14, 2026
A scoping review of randomized controlled trials in the early phase of the COVID-19 pandemic: country-level research response to COVID-19 therapeutics and vaccinesHiroki Saito, Mai Inada, Satoshi Miike, et al.
International Journal of Hematology|May 29, 2012
Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia: the JALSG GML200 StudyAtsushi Wakita, Shigeki Ohtake, Satoru Takada, et al.
Journal of Medicinal Chemistry|March 8, 2023
Discovery of Novel Substrate-Competitive Lysine Methyltransferase G9a Inhibitors as Anticancer AgentsYosuke Nishigaya, Shohei Takase, Tatsunobu Sumiya, et al.
Blood Neoplasia|September 15, 2025
Discovery of a novel class NSD2 inhibitor for multiple myeloma with t(4;14)<sup></sup>Sae Matsuoka, Naoki Osada, Hirokazu Kubota, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2024
Structure-based development of novel substrate-type G9a inhibitors as epigenetic modulators for sickle cell disease treatmentYosuke Nishigaya, Shohei Takase, Tatsunobu Sumiya, et al.
PNAS Nexus|October 12, 2023
Acidic extracellular pH drives accumulation of N1-acetylspermidine and recruitment of protumor neutrophilsMiki Kato, Keisuke Maeda, Ryuichi Nakahara, et al.
Pageof 55

Showing results (491-500 of 543) with videos related to

Sort By:
Pageof 55
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 7, 2017
Management of infection during chemotherapy for acute leukemia in Japan: a nationwide questionnaire-based survey by the Japan Adult Leukemia Study GroupShun-Ichi Kimura, Hiroyuki Fujita, Hideaki Kato, et al.
International Journal of Hematology|January 8, 2011
Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study GroupMinoru Yoshida, Nobu Akiyama, Hiroyuki Fujita, et al.
Journal of Atherosclerosis and Thrombosis|February 21, 2024
Impaired Cholesterol Efflux Capacity rather than Low HDL-C Reflects Oxidative Stress under Acute Myocardial InfarctionKentaro Oniki, Masatsune Ogura, Erika Matsumoto, et al.
Oncology Reports|September 18, 2004
1-hexylcarbamoyl-5-fluorouracil + cyclophosphamide + tamoxifen versus CMF + tamoxifen in women with lymph node-positive breast cancer after primary surgery: a randomized controlled trialTakeshi Tominaga, Morihiko Kimura, Taro Asaga, et al.
BMC Infectious Diseases|March 14, 2026
A scoping review of randomized controlled trials in the early phase of the COVID-19 pandemic: country-level research response to COVID-19 therapeutics and vaccinesHiroki Saito, Mai Inada, Satoshi Miike, et al.
International Journal of Hematology|May 29, 2012
Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia: the JALSG GML200 StudyAtsushi Wakita, Shigeki Ohtake, Satoru Takada, et al.
Journal of Medicinal Chemistry|March 8, 2023
Discovery of Novel Substrate-Competitive Lysine Methyltransferase G9a Inhibitors as Anticancer AgentsYosuke Nishigaya, Shohei Takase, Tatsunobu Sumiya, et al.
Blood Neoplasia|September 15, 2025
Discovery of a novel class NSD2 inhibitor for multiple myeloma with t(4;14)<sup></sup>Sae Matsuoka, Naoki Osada, Hirokazu Kubota, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2024
Structure-based development of novel substrate-type G9a inhibitors as epigenetic modulators for sickle cell disease treatmentYosuke Nishigaya, Shohei Takase, Tatsunobu Sumiya, et al.
PNAS Nexus|October 12, 2023
Acidic extracellular pH drives accumulation of N1-acetylspermidine and recruitment of protumor neutrophilsMiki Kato, Keisuke Maeda, Ryuichi Nakahara, et al.
Pageof 55